Pulmonary Toxicity Secondary to Bleomycin. A Case Report.
Article Sidebar
Main Article Content
Abstract
Antineoplastic pulmonary toxicity is highly variable depending on the pharmacological group; bleomycin is one of the drugs in which this event has been reported. This cytostatic can injure the pulmonary endothelium and the alveolar epithelium to lead to an inflammatory and fibrotic process of the interstitium with potentially fatal repercussions.
The following is a case of interstitial disease type organizing pneumonia associated with bleomycin in a 68-year-old patient diagnosed with classical Hodgkin lymphoma of nodular sclerosis type, with imaging study prior to normal treatment.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
O’Sullivan JM, Huddart RA, Norman AR, Nicholls J, Dearnaley DP, Horwich A. Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumors. Ann Oncol 2003; 14: 91–96. Doi: 10.1093/annonc/mdg020.
Reinert T, Baldotto CSR, Nunes FAP, Scheliga AAS. Bleomycin-induced lung injury. J Cancer Res 2013;480608. Doi: 10.1155/2013/480608
Fyfe AJ, McKay P. Toxicities associated with bleomycin. J R Coll Physicians Edinb 2010;40(3):213-5. Doi: 10.4997/JRCPE.2010.306.
Sridhar S, Kanne JP, Henry TS, Revels JW, Gotway MB, Ketai LH. Medication-induced Pulmonary Injury: A Scenario- and Pattern-based Approach to a Perplexing Problem. RadioGraphics 2022;42(1):38-55. Doi: 10.1148/rg.210146.
Skeoch S, Weatherley N, Swift AJ et al. Drug-induced interstitial lung disease: a systematic review. J Clin Med 2018;7(10):356. Doi: 10.3390/jcm7100356.
Torrisi JM, Schwartz LH, Gollub MJ, Ginsberg MS, Bosl GJ, Hricak H. CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity. Radiology 2011;258(1):41–56. Doi: 10.1148/radiol.10092129.
Naranjo C, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharm Ther 1981; 30: 239-45. Doi: 10.1038/clpt.1981.154.